Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about IGF-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | IGF-1 |
| Key Genes/Proteins | Adiponectin, AGING, AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMPK |
| Related Diseases | Aging, Als, ALS, Alzheimer |
| Related Pathways | Akt, Amyloid |
Knowledge base pages for this entity
graph TD
IGF_1["IGF-1"]
style IGF_1 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
IGF_1 -->|"activates"| Myogenesis["Myogenesis"]
IGF_1 -->|"activates"| PI3K_Akt_mTOR["PI3K-Akt-mTOR"]
IGF_1 -->|"regulates"| insulin_signaling["insulin signaling"]
IGF_1 -->|"activates"| Ms["Ms"]
IGF_1 -.->|"inhibits"| Alzheimer["Alzheimer"]
IGF_1 -.->|"inhibits"| Aging["Aging"]
IGF_1 -.->|"inhibits"| Inflammation["Inflammation"]
IGF_1 -.->|"inhibits"| Als["Als"]
KIF5B([KIF5B]) -->|"regulates"| IGF_1
ERK["ERK"] -->|"upstream_of"| IGF_1
AND([AND]) -->|"activates"| IGF_1
DNM1L([DNM1L]) -->|"activates"| IGF_1
NEURON([NEURON]) -->|"activates"| IGF_1
MICROGLIA([MICROGLIA]) -->|"activates"| IGF_1
MITOCHONDRIAL_DYSFUNCTION([MITOCHONDRIAL DYSFUNCTION]) -->|"activates"| IGF_1
MTORC1([MTORC1]) -->|"activates"| IGF_1
IL_6([IL-6]) -.->|"inhibits"| IGF_1
BDNF([BDNF]) -->|"activates"| IGF_1| Target | Relation | Type | Str |
|---|---|---|---|
| Synaptic Plasticity | promotes | process | 0.85 |
| Myogenesis | activates | process | 0.85 |
| PI3K-Akt-mTOR | activates | pathway | 0.70 |
| insulin signaling | regulates | pathway | 0.70 |
| ALS | activates | disease | 0.65 |
| Aging | biomarker_for | disease | 0.65 |
| Inflammation | biomarker_for | disease | 0.65 |
| Senescence | biomarker_for | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Ms | regulates | disease | 0.65 |
| Aging | activates | disease | 0.65 |
| Alzheimer | regulates | disease | 0.65 |
| Fibrosis | biomarker_for | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Dementia | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Senescence | associated_with | disease | 0.65 |
| Alzheimer | inhibits | disease | 0.65 |
| Aging | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Inflammation | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Mtor | regulates | pathway | 0.60 |
| Fibroblast | associated_with | cell_type | 0.60 |
| Chemokine | biomarker_for | protein | 0.60 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| Bdnf | biomarker_for | protein | 0.60 |
| Ghrelin | activates | protein | 0.60 |
| Leptin | biomarker_for | protein | 0.60 |
| Adiponectin | activates | protein | 0.60 |
| Interleukin | activates | protein | 0.60 |
| AND | activates | gene | 0.60 |
| INFLAMMATION | inhibits | gene | 0.60 |
| AGING | associated_with | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| MITOCHONDRIAL DYSFUNCTION | activates | gene | 0.60 |
| INFLAMMATION | activates | gene | 0.60 |
| EXERCISE | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-47ab2be5 | targets | hypothesis | 0.90 |
| KL | modulates | protein | 0.85 |
| KIF5B | regulates | gene | 0.80 |
| ERK | upstream_of | pathway | 0.75 |
| IL-6 | associated_with | gene | 0.66 |
| OXIDATIVE STRESS | activates | gene | 0.60 |
| ALZHEIMER | activates | gene | 0.60 |
| DEPRESSION | activates | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | activates | gene | 0.60 |
| TRKB | activates | gene | 0.60 |
| IFN | activates | gene | 0.60 |
| IFN-Γ | activates | gene | 0.60 |
| IL-1 | activates | gene | 0.60 |
| FGF21 | activates | gene | 0.60 |
| NGF | activates | gene | 0.60 |
| MTOR | contributes_to | gene | 0.60 |
| IRS1 | contributes_to | gene | 0.60 |
| DEMENTIA | therapeutic_target | gene | 0.60 |
| MAPK | therapeutic_target | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| SYP | activates | gene | 0.60 |
| EXERCISE | activates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| NEUROTOXICITY | activates | gene | 0.60 |
| CYTOKINES | activates | gene | 0.60 |
| ALZHEIMER | contributes_to | gene | 0.60 |
| NPY | activates | gene | 0.60 |
| TAU | inhibits | gene | 0.60 |
| C-JUN | activates | gene | 0.60 |
| BDNF | biomarker_for | gene | 0.60 |
| ROS | associated_with | gene | 0.60 |
| TLR4 | activates | gene | 0.60 |
| AGING | activates | gene | 0.60 |
| PER | activates | gene | 0.60 |
| FOXO1 | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| ALZHEIMER | regulates | gene | 0.60 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| INS | activates | gene | 0.60 |
| FGF21 | biomarker_for | gene | 0.60 |
| MITOCHONDRIA | biomarker_for | gene | 0.60 |
| GPNMB | activates | gene | 0.60 |
| COMPLEMENT | activates | gene | 0.60 |
| VIMENTIN | biomarker_for | gene | 0.60 |
| VIM | biomarker_for | gene | 0.60 |
| CXCL10 | biomarker_for | gene | 0.60 |
| CX3CL1 | biomarker_for | gene | 0.60 |
| APOPTOSIS | biomarker_for | gene | 0.60 |
| APP | activates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Fusing IGFBPL1 to IGF-1 for Receptor-Mediated BBB Transcytos | 0.552 | drug delivery | Can IGFBPL1 therapeutics effectively cro |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning IGF-1 in their description or question text
No additional research found